Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 17

Results For "diagnostic"

830 News Found

Truvian Health bags FDA clearance for CBC on TruVerus System
Drug Approval | January 28, 2026

Truvian Health bags FDA clearance for CBC on TruVerus System

TruVerus is the only FDA cleared, multi-modal platform capable of delivering comprehensive routine testing from a single lithium heparin sample


Telangana unveils ambitious next-gen Life Sciences Policy at Davos
News | January 24, 2026

Telangana unveils ambitious next-gen Life Sciences Policy at Davos

A dedicated Life Sciences Innovation Fund, scalable up to Rs. 1,000 crore, will catalyze early- and growth-stage innovation, support deep-tech ventures – particularly biotherapeutics


Functional Gut Clinic launches UK’s first boutique GI clinical trials division
Clinical Trials | January 23, 2026

Functional Gut Clinic launches UK’s first boutique GI clinical trials division

Gastrointestinal conditions affect millions across the UK, yet research in the field has often been fragmented, slow, or under-resourced


DNA Nanorobots & AI could slash drug development times, Nanovery CEO says
Biotech | January 20, 2026

DNA Nanorobots & AI could slash drug development times, Nanovery CEO says

DNA nanorobots—tiny, self-assembling machines capable of detecting diseases in blood samples within 2–4 hours


Mahajan Imaging & Labs launches AI-driven blood test to detect Alzheimer’s early
News | January 20, 2026

Mahajan Imaging & Labs launches AI-driven blood test to detect Alzheimer’s early

Over 8.8?million Indians aged 60 and above currently live with dementia,


Bayer acquires Attralus’ cardiac amyloidosis imaging agents
News | January 16, 2026

Bayer acquires Attralus’ cardiac amyloidosis imaging agents

The deal to acquire AT-01 (124-Iodine-evuzamitide) and AT-05 (PAR-Peptide + technetium-99m) underscores Bayer’s commitment to expanding in molecular imaging and advancing precision cardiology


Bayer acquires Attralus’ cutting-edge cardiac amyloidosis imaging agents
News | January 14, 2026

Bayer acquires Attralus’ cutting-edge cardiac amyloidosis imaging agents

The acquisition of AT-01 (124-Iodine-evuzamitide) and AT-05 (PAR-Peptide + technetium-99m) positions Bayer at the forefront of cardiac amyloidosis diagnostics


Stereotaxis scores FDA nod for groundbreaking MAGiC robotic heart catheter
Medical Device | January 08, 2026

Stereotaxis scores FDA nod for groundbreaking MAGiC robotic heart catheter

The MAGiC catheter is designed for robotically-navigated cardiac ablation procedures


Dr. Lal PathLabs launches tech-driven personalized wellness center 'Sovaaka'
News | January 07, 2026

Dr. Lal PathLabs launches tech-driven personalized wellness center 'Sovaaka'

Sovaaka offers a deeply personalised diagnostics-led wellness experience that goes beyond routine health checks


Thyrocare appoints Rajdeep Panwar as Chief Commercial Officer
People | January 06, 2026

Thyrocare appoints Rajdeep Panwar as Chief Commercial Officer

Rajdeep is an accomplished business leader with a strong techno-commercial background in the healthcare and diagnostic sector